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Foreword 
 
 
The work contained in this White Paper reflects the efforts from health plans, employers, 
consultants, and providers to define a set of recommendations – Best Practices – that 
have the potential to improve the measurement of provider efficiency and the science 
behind it. While the paper focuses on efficiency, all the contributors acknowledge that 
measuring efficiency should be done in conjunction with measuring effectiveness of care, 
so that consumers, purchasers and payers can better understand and identify the value of 
the services being delivered, and providers can better understand the steps they need to 
take to improve the value of services offered. 
 
None of the parties would suggest that these are the final (or the only) word in provider 
efficiency measurement, quite the contrary, which is why we have referred to this paper 
as Version 1.0. Nor do we suggest that all recommendations should be adhered to strictly. 
In fact, we recognize that many readers of this paper will struggle with how to implement 
some of the recommendations, or with how it will impact their organization. In doing so, 
they should recognize that, as an industry, we are still in the early stages of developing 
adequate universally accepted rules on how to measure the efficiency with which doctors, 
hospitals and other care providers deliver services.  As such, it will be extremely 
important as we go forward to closely collaborate and create a community of continuous 
learning, understanding better the power of analysis when some of the recommendations 
are not applied as opposed to being applied.  Continuing the experimentation will allow 
all of us to arrive at a better model, and we are committed to updating the 
recommendations periodically to reflect new findings. 
 
This continuous learning should be approached in the same spirit as the development of 
the Linux software code – anyone can take what we have, but contribute back any 
improvements you can make.  It is only through this sort of collaboration, where best 
practices will be shared openly, that we can advance the science, reduce the barriers to 
implementation and jointly create a better health care system. To that end, an on-line 
forum has been set-up at www.regence.com/research where the discussion we have 
started here can be continued. 
 
 
The Leapfrog Group 
Bridges To Excellence 
 
With the participation of: 
NCQA 
The Pacific Business Group on Health 
Partners Healthcare System 
The Regence Group
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1) Executive Summary 
 
A decade of escalating health care costs combined with a growing focus by the 
Institute of Medicine (IOM) and others on the deficiencies in the safety and quality of 
patient care have created considerable momentum around the concept of measuring both 
provider clinical quality and provider cost efficiency (cost efficiency from the payer’s 
perspective).  The science of measuring physician and hospital quality has advanced 
considerably in recent years.  Organizations like the Joint Commission for the 
Accreditation of Healthcare Organizations (JCAHO) and the National Committee for 
Quality Assurance (NCQA) have developed standard measures that are now widely used 
throughout health care.  Many of those measures have been reviewed through the 
National Quality Forum’s consensus-based process and adopted by health plans and 
rating agencies.  As a result, there is good understanding within the industry on how to 
measure health care quality at various levels (in particular health plan and hospital 
levels), even if, regrettably, there is not complete uniformity in the application of those 
measures, or universal achievement of high performance on these measures. 
 
The same cannot be said of efforts to measure efficiency.  Until now, there lacked 
a systematic, empirically informed and consensus-based process to understand how best 
to measure cost efficiency.  Instead, each individual stakeholder has had a tendency to 
approach this effort separately, which has decreased the industry’s ability to learn from 
natural experiments, understand and catalog best practices, and collaborate on relevant 
research.  As a result, organizations that have introduced efficiency measurement 
initiatives have often been met with resistance from doctors and hospitals on (a) the 
meaningfulness and validity of the results, and (b) the lack of transparency in the 
underlying measurement methodologies.   However, the need for valid, reliable, and 
actionable information on provider efficiency remains very high. Payers and 
purchasers/employers (and increasingly consumers as a result of changed health benefits 
designs) have understandably had a keen interest in identifying doctors and hospitals that 
consistently deliver good clinical outcomes without wasting resources, and using that 
information to support benefit designs, network management and public report cards that, 
together or separately, might induce patients to choose more efficient providers.   
 
The goal of this White Paper is to launch an ongoing process that will provide 
guidance to all stakeholders based on available knowledge about efficiency measurement. 
The guidance is provided in the form of principles and recommendations that are 
believed to be acceptable to – if not necessarily embraced wholesale by – multiple 
stakeholders.  These recommendations are not intended to represent the “last word” on 
provider efficiency, as both the art and science of efficiency measurement are still in their 
infancy and we expect them to grow.  Rather, they are intended to create a framework 
that is sound enough to use as a basis for measurement today, and to act as a catalyst for 
stimulating the evolution of measurement as our knowledge and understanding of this 
field grows. To that end, an online learning community has been established at 
www.regence.com/research to facilitate the continued sharing of knowledge. 
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Furthermore, during the next few years, the NCQA, a key collaborator in this 
effort, will develop evaluation methods that will help determine the extent to which 
health care organizations measure physician and hospital performance following 
principles set forth in this paper. NCQA is currently working with many national experts 
and stakeholder representatives in order to publish a first set of evaluation methods 
(standards) by July 2005. It is expected that NCQA will be able to evaluate health care 
organizations wanting to demonstrate their adherence to these standards by the latter half 
of 2005.  
 
NCQA’s efforts in this area, referred to as the Quality Plus Initiative, are part of 
its overall work to refine its evaluation methods to focus on critical areas where health 
care organizations (managed care organizations and preferred provider organizations) can 
be expected to significantly add value for their members. For a more detailed discussion 
of NCQA’s methods and implementation timetable see 
www.ncqa.org/Programs/Qualityplus. Until the NCQA’s work is complete, the White 
Paper will be periodically updated to reflect new knowledge and understanding from real 
world applications in this field through the continued work of many organizations. 
 
Our underlying belief is that for hospital or physician efficiency measurements to 
be widely accepted in the market, they should be feasible to implement for health plans, 
credible and reliable for consumers, and fair, equitable and actionable for providers. That 
requires certain conditions to be met. 
 
First, it is important to incorporate enough recent data to develop a statistically 
reliable determination of provider efficiency.  If some data elements are unavailable, they 
should be omitted uniformly to ensure the comparability of diverse data sources. 
However, some empirical evidence suggests that pharmacy data is important for 
measuring physician efficiency.  Reports should only be issued for physicians or 
hospitals with substantial reportable cases; we offer suggestions regarding reporting 
thresholds and evidence supporting the recommendation. 
 
Second, we recommend analyzing the data using industry standard episode 
grouping methodologies, and applying robust case mix and severity of illness 
adjustments.  Even with standard episode groupings and risk adjustment, it is still 
important to restrict comparison groups to truly comparable facilities or physicians. To 
that end, we are publishing a separate study that analyzes potential adjustment factors that 
should be applied to certain types of hospitals when comparing them to non-pure peers 
using a price-sensitive efficiency index. 
 
Third, we recommend attributing episodes only to providers who have a 
substantial impact on the episode of care.  We suggest a threshold of at least 25% of total 
professional costs, and believe that it would be acceptable to attribute cases to multiple 
providers if they each had a substantial impact on the episode of care. We offer some 
evidence in support of that threshold and methodology. 
Version 1.0 12-31-2004 Page 7 of 51 
All rights reserved, The Leapfrog Group, Bridges To Excellence   
 
Finally, we recommend that provider performance reporting should distinguish 
between differences in utilization and cost per unit.  All performance should be reported 
in valid statistical groupings to reflect the relative performance of the provider, avoiding 
strict numerical rankings where the risk of misclassification is high. Generally, reporting 
performance on efficiency should be linked to reporting performance on quality to better 
understand, measure and communicate the value that is delivered by physicians and 
hospitals. 
 
We recognize that not all organizations will, or can, apply all the 
recommendations listed in this paper.  We also recognize that the science, 
experimentation and research on measuring efficiency should continue in earnest in an 
open learning community.  To that end, we recommend that any organization measuring 
provider efficiency (1) clearly communicate to all stakeholders (in particular providers 
and purchasers) the specific methodology used in arriving at the results and any rationale 
for varying from the recommendations in this paper, (2) publish the confidence interval 
around the results, and (3) participate in an on-line learning forum at 
www.regence.com/research to share the results of their work and advance the science in 
this field. 
 
We also greatly encourage the developers of models and methodologies that 
measure provider efficiency to make their models available to researchers at very low or 
no cost, and to develop “freeware” versions of their products that can be used by 
providers and others to help improve their performance. 
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2) Overview 
 
a) The Need 
The science of measuring physician and hospital care effectiveness has advanced 
considerably in the past decade. Organizations like the Joint Commission on Healthcare 
Organizations (JCAHO) and the National Committee for Quality Assurance (NCQA) 
have developed standardized performance measures that are now widely used throughout 
health care.  Many of those measures have been reviewed through the National Quality 
Forum’s consensus-based process and adopted, and are now widely accepted by multiple 
stakeholders.  However, the same is not true when it comes to measuring physician or 
hospital efficiency.  The Institute of Medicine, in Crossing the Quality Chasm, defined 
efficiency as avoiding waste1.  In economic theory, efficiency is defined as the physical 
relation between resources and health outcome “…when the maximum set of possible 
improvements is obtained from a set of resource inputs” (Palmer & Torgerson, BMJ 
1999).  
 
Throughout this document the term efficiency is defined as a relative level of 
resource consumption, and associated costs, in the production of health care services – 
cost-efficiency (without an explicit link to the clinical outcomes of those services), form 
the payer’s perspective. While we recognize that economists may consider this definition 
inappropriate, we will use it here to reflect the current terminology used by hundreds of 
health plans and purchasers. 
 
When judging the relative efficiency of health plans “total cost per member per 
month (PMPM)” has been widely used as a relevant performance metric (splitting out the 
administrative cost portion from the medical cost portion). However, while there is broad 
consensus that the unit price of individual physician or hospital services is grossly 
inadequate and flawed in measuring efficiency, an equivalent metric to PMPM in 
monitoring physician or hospital efficiency has been elusive.  At the same time, 
widespread implementation and dissemination of standardized measures of provider 
efficiency are key to enabling providers to focus their process improvement efforts as 
well as allowing consumers and purchasers to select physicians, hospitals and other 
health care professionals based on considerations of both effectiveness and efficiency. In 
turn, consumers’ and purchasers’ ability to seek out and reward high-performing 
providers may foster substantial improvements in the value of health care services by 
encouraging physicians and hospitals to improve their efficiency.  
 
Despite the lack of consensus on how to measure provider efficiency, several 
methods and associated software applications are available today to better understand the 
efficiency of physicians and hospitals.  These applications have been developed for use 
with administrative claims databases that are comprised of medical, pharmacy, 
laboratory, and ancillary services. While administrative claims databases have substantial 
shortcomings, they are mostly standardized and ubiquitous, and are very often the only 
available source of information on resource utilization. The claims filed for these services 
                                                 
1 Institute of Medicine Committee on Quality of Health Care in America. Crossing the Quality Chasm: A 
New Health System for the 21st Century. Washington, D.C.: National Academy Press, 2001, page 6. 
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represent both the nature and volume of services provided in the treatment of specified 
diseases and conditions.  In general, the results generated from these applications have 
typically been limited to uses focused on health plan network design and management 
functions. More recently, these results have also been tied to benefit designs and public 
reporting. 
 
Over the years, these methods have identified a common “unit of measure” for 
comparing provider efficiency, the episode of care – an event that is part of a patient’s 
total care, but forms a separate unit within that whole – and in this Paper we will use the 
term episode in a generic way, not referring to any specific methodology. However, the 
underlying methods, including required data sources and data elements, needed statistical 
adjustments, and other application rules can vary substantially. Reducing the variation in 
methods will make information on provider efficiency more actionable by all 
stakeholders.  And improving the reliability of the results from these analyses will reduce 
the potential for misclassifying providers and leading consumers and purchasers to 
inaccurate conclusions with respect to a provider’s efficiency. 
 
b) Scope and Purpose of This Effort 
In response to the need for purchasers and health plans to share and consistently 
use good practices in measuring provider efficiency, the Leapfrog Group and Bridges To 
Excellence assembled a group of industry stakeholders and experts to identify, endorse 
and, wherever possible, field test a set of principles for measuring hospital and physician 
efficiency at the most useful granular level.  
 
These principles and their associated measures of efficiency are intended to 
support the concept of value-based purchasing and promote the judicious use of 
healthcare resources. In designing these principles, this team of experts has  
1) Taken steps to ensure that the principles consider the perspectives of 
payers/purchasers, providers and consumers  
2) Created a set of recommendations that are not unduly burdensome to 
adopt  
3) Made strong effort to coordinate and synchronize with other similar 
efforts2 
 
The scope of the project is limited to defining principles and guidelines for using 
existing methods, rather than defining new or different methods, or defining specific 
efficiency measures3. Furthermore, we are not advancing specific recommendations on 
how purchasers and plans should use efficiency measures to promote improvement, for 
the management of provider networks, pay-for-performance initiatives, or consumer 
decision support. However, we strongly suggest (1) that measurement results and 
methodologies used in generating the results be shared with the physicians and hospitals 
being measured; (2) that efforts be taken to understand the variances in efficiency 
                                                 
2 Multiple purchaser initiatives, including Care Focused Purchasing, the Human Resource Policy 
Association’s Affordable initiative, the Leapfrog Group’s National Reward Program, have agreed to adopt 
the recommendations of the White Paper 
3 Existing methods include (but are not limited to) Symmetry’s Episode Treatment Groups, DxCG’s Risk-
Adjusted Episodes, Medstat Episode Grouper, 3M’s Clinical Risk Grouper 
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performance and, where possible, how improvements may be made to improve 
performance in a timely manner; and (3) that measuring efficiency without understanding 
the clinical output fails to measure the value of services provided, and that, as a 
consequence, the two should be linked.  
 
c) Meeting Customer and Stakeholder Needs 
In order to structure our approach to this effort, to identify the most important 
product attributes (principles of measurement), and to ensure that all relevant 
stakeholders’ perspectives are considered in an appropriate fashion we followed an 
approach referred to as Design For Six Sigma (DFSS). (See Appendix (a)(i) for details on 
the DFSS process and its output with respect to this project, including designation of 
customers and stakeholders, expression of customer and stakeholder needs, and outlining 
of key processes for recommendations). 
 
As part of the DFSS process we identified purchasers/payers (including health 
plans) and consumers as customers, while providers, accrediting organization, and benefit 
consultants were considered stakeholders. While the distinction is important because 
customer needs take precedence over stakeholder needs, the recommendations outlined in 
this paper reflect the perspectives and needs of both customers and stakeholders. 
 
Customer and stakeholder needs were gathered through key informant interviews 
and focus groups, conducted either as part of this or related efforts4, and were then 
consolidated and translated into a core set of product attributes. 
 
d) Program Attributes 
At every step, specific recommendations were evaluated according to their 
potential impact on a set of critical program attributes. The higher the potential impact, 
the stronger the recommendation.  The attributes are: 
• Actionable: The output from the applications used to measure efficiency 
should be actionable by plans and providers, enabling them to identify 
opportunities for improvement and their relative performance when compared 
to others 
• Operational and feasible: Recommendations have to be operationally 
focused and feasible for plans/benefit administrators and providers to 
implement without creating undue burden on staff and resources 
• Fair: The methods used in calculating efficiency and the application of those 
methods should reflect the overall, true cost of care and the appropriate locus 
of control (e.g. providers should not be held accountable for the impact of 
benefit design/cost sharing). The methods should allow for appropriate risk-
adjustment, peer to peer comparisons, the ability to understand the influence 
of unit price relative to resource use, and account for the value of care 
coordination and other care management processes 
• Credible and reliable: All methods used should be sound, evidence-based, 
valid, and produce timely results 
                                                 
4 de Brantes, F.S., Galvin, R.S., M.D., Lee, T., M.D., Bridges to Excellence – A Business Case for Quality: 
Journal of Clinical Outcomes Management, August 2003 
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• Equitable: The use of efficiency measures to evaluate providers should be 
reasonable, avoid gaming by any party, and the publication of these data 
should lead to overall improvements benefiting purchasers/plans, providers 
and consumers 
   
e) Key Recommendations 
The recommendations are categorized in three areas of focus that include the main 
process steps used in creating episodes of care and then using those episodes to determine 
a provider’s relative level of performance:   
• Data input, or needed data elements: This is the stage during which critical 
data elements are gathered 
• Application rule sets, or required statistical adjustments: These are the 
rules that are applied to the data in measuring the care that patients 
experience during the course of a year and constructing a valid episode  
• Data output, or generating valid information: This is the stage during 
which episodes of care are attributed to specific providers, providers are then 
included in peer groups, and their relative level of efficiency is determined 
and reported 
 
Using a DFSS tool referred to as the “Quality Functional Deployment” or QFD 
(see Appendix (a)(ii)), the team identified a series of product requirements in each of 
these process steps that could significantly impact critical product attributes.  We focused 
on the requirements most likely to make the assessment of hospital or physician 
efficiency actionable, operational and feasible, fair, credible and reliable, and equitable. 
These key recommendations are summarized on the following page. 
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Key recommendations (detailed in Section 3) 
Incorporate enough recent data to 
develop a statistically reliable 
determination of provider 
efficiency 
In most cases this will require at least two years of 
data, based on incurred claims. It is important to 
note that using older data may distort current 
performance, and that, as such, measuring efficiency 
requires the use of as much recent data as available 
Ensure the comparability of 
diverse data sources 
For example, currently, Medicare data should only 
be blended with commercial insured data if 
pharmacy data are excluded. Data from different 
lines of commercially insured members (i.e. HMO, 
PPO, POS) should be blended only if the database 
attributes are similar 
Tie information to patients first 
and then tie the patients to 
providers 
It’s important to center the episodes on the patient 
and then determine how best to attribute the patient’s 
care to a physician and/or hospital 
Employ robust case-mix and 
severity of illness adjustments 
Blending different populations also assumes that the 
risk adjustment will be effective across these 
populations – e.g., that episode of care, risk 
assessment, and DRG groupers allow you to compare 
elderly (Medicare) and non-elderly populations in a 
straightforward way.  Equally important is the need 
to severity-adjust across the patient’s entire health 
status, not just the specific condition in the episode 
Employ episode-grouping 
methodology (See Section 4 (b) 
for discussion) 
For example, chronic disease episodes often include 
a minimum of one full year of related claims, and 
should exclude claims unrelated to the diagnosis. 
Acute conditions generally have a chronological 
“window” during which any related care is included 
within the episode 
Attribute episodes only to 
providers who have a substantial 
impact on the episode of care (See 
Appendix (d) (i) for discussion) 
Our analysis shows that episodes should be first 
attributed to treating physicians whose professional 
claims represent a significant percentage of 
professional claims within an episode, and whose 
total claims costs account for at least 25% of total 
“eligible provider” claims in dollar terms. 
Furthermore, episodes can be attributed to all other 
eligible providers (including hospitals) whose total 
claims account for 25% or more of eligible costs 
within that episode. In some rarer instances episodes 
can be attributed to the physician with most face-to-
face encounters 
Report on efficiency only for 
physicians or hospitals with 
substantial reportable cases, or if 
using a smaller sample size, 
understand and communicate 
Physicians should be included in the comparison 
group only if they have a sufficient number of valid 
episodes across all diagnoses and procedures, and 
there are a sufficient number of other physicians of 
the same specialty type in the comparison group to 
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clearly the decrease in the 
confidence interval around the 
result (see Section 4 (c) and 
Appendix (f)(i) for Sample Size 
Impact analysis) 
allow for a valid comparison. Reports should 
explicitly state the statistical level of significance of 
results and the risk of misclassification. 
Hospitals should only be included if they have a 
sufficient number of episodes for any given procedure 
and of procedure-specific episodes across hospitals 
in the comparison group.  Again, reports should 
explicitly state the statistical level of significance of 
results and the risk of misclassification. 
As claims age increases the minimum sample sizes 
should increase to compensate for changes over time 
in the underlying use of resources 
Distinguish between utilization 
and cost per unit in reporting 
As much as possible, efficiency scores assigned to 
providers should clearly differentiate the portion of 
the score that is attributable to price (i.e. fee for 
service) from the portion that is attributable to 
resource use (number of service units) 
Limit the pool of providers from 
which an average is calculated to 
truly comparable facilities or 
physicians, or recognize that 
comparisons across all facilities 
and physicians may not be 
possible 
Providers should be compared with their peers (i.e. 
cardiologists compared to other cardiologists, 
pediatricians with other pediatricians). Since pure 
peer-to-peer comparisons of hospitals in any region 
is difficult (e.g. only one academic health center), to 
the extent possible, adjustments for the mission of the 
hospital may be warranted when using a price-
sensitive efficiency index (see Appendix (g) for 
discussion). Similarly, and to the extent possible, an 
allowance for the socio-economic mix of patients may 
be appropriate when comparing physicians. In both 
cases further research is needed to determine the 
level and type of adjustments that may be needed 
Report performance in valid 
statistical groupings, and avoid 
numerical ranking 
Rankings should reflect the relative performance of a 
provider (i.e. top performer, above average, average, 
below average) as opposed to an absolute score (1st, 
2nd, 3rd, etc…). Where possible, confidence intervals 
should be reported and displayed.  In addition, the 
relative performance should be based as much as 
possible on valid external benchmarks 
In the absence of concrete, 
scientifically valid standards for 
efficiency, we recommend 
benchmarking efficiency 
performance with peers – even 
though they may not represent the 
highest standard achievable 
Ideally, benchmarking should be done from data 
sources external to the plan in order to better 
determine the relative performance of a plan-specific 
study cohort. In addition, it is difficult to determine 
the appropriateness of episodes of care delivered, 
from administrative data alone 
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f) Conclusions 
To address the legitimate concerns of stakeholders, it was necessary to make 
some compromises and trade-offs in order to reach a result that was fair, reliable and 
actionable.   For example, some stakeholders suggested that we focus on assessing 
efficiency at a more aggregated level for physicians, arguing that teams deliver care.  
However, even within integrated groups, the performance of individual physicians has a 
substantial impact on overall efficiency, and reporting on only group performance would 
likely obscure opportunities for improvement in efficiency of individual members of the 
group.  As such, our recommendations focus on reporting at the lowest unit of measure 
possible, ideally the individual physician. 
 
We note further that our recommendation to require an attribution threshold 
implies that some episodes of care not be evaluated.  Similarly, our recommendation to 
require a minimum number of episodes for any provider will prevent the profiling of 
many providers; however, for most health plans the providers on whom a profile can be 
established are those with higher volumes and who represent a large portion of the total 
care delivered to covered members.  We also note that health plans that are smaller or in 
more fragmented markets can enhance their opportunity to do meaningful efficiency 
profiling with data aggregated across a geographic region. A practical implication is that 
health plans will need to increasingly improve the richness of data collected (beyond the 
strict limits of what is needed to pay providers), and providers will have to improve the 
accuracy of their claims submission. 
 
This White Paper, through the efforts of the stakeholders that have contributed to 
it, has gathered the best available knowledge about efficiency measurement to formulate 
a set of principles and standards acceptable to – if not necessarily embraced wholesale by 
– multiple stakeholders. We believe that these principles and standards should yield valid, 
fair, reliable and actionable information on providers’ efficiency in delivering health care 
services 
 
These standards are not intended to represent the “last word” on provider 
efficiency, as both the art and science of efficiency measurement are still in their infancy 
and we expect them to grow.  Rather, they are intended to create a framework that is 
sound enough to use as a basis for measurement today, and to act as a catalyst for 
stimulating the evolution of measurement as our knowledge and understanding of this 
field grows.  
 
The NCQA, a key collaborator in this effort, will develop evaluation methods that 
will allow a determination of the extent health care organizations measure physician and 
hospital performance following principles set forth in this paper. NCQA is currently 
working with many national experts and stakeholder representatives in order to publish a 
first set of evaluation methods (standards) by July 2005. It is expected that NCQA will be 
able to evaluate health care organizations wanting to demonstrate their adherence to these 
standards by the latter half of 2005.  
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NCQA’s efforts in this area, referred to as the Quality Plus Initiative, are part of 
its overall work to refine its evaluation methods to focus on critical areas where health 
care organizations (managed care organizations and preferred provider organizations) can 
be expected to significantly add value for their members. For a more detailed discussion 
of NCQA’s methods and implementation timetable see 
www.ncqa.org/Programs/Qualityplus.  
 
Until the NCQA’s work is complete, the White Paper will be updated regularly to 
reflect new knowledge and understanding from real world applications in this field 
through the continued work of many organizations. 
 
The hope is that the recommendations in this White Paper will be widely adopted 
throughout the industry, and that a continuous learning community will be created where 
results from more experimentation can be shared and the science improved. At the very 
least, the two sponsoring organizations have agreed to incorporate the recommendations 
into their initiatives.  In addition, the Regence Group has agreed to host an on-line 
learning community at www.regence.com/research where the discussions started by the 
paper can continue, and where researchers and other users of efficiency data or 
methodologies can contribute their experiences and findings. 
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3) Table of Recommendations 
 
Data Input/Needed 
Data Elements: 
Use as much recent data as possible, and whenever possible 
use all medical claims, including facility, physician, 
pharmacy, and ancillary services.  Claims should be on an 
incurred basis, reflecting the “allowed amount” (negotiated 
reimbursement rates prior to application of member out-of-
pocket benefit rules – i.e. includes expected patient cost-
sharing to be collected by the clinician). 
Data should be as uniform as possible to enable valid 
provider comparisons.  For example, episodes that are 
constructed using medical, pharmacy, and other claims data 
should not be combined with episodes that are constructed 
with medical claims only. 
When measuring physician efficiency, pharmacy data 
should be included whenever possible (see Section 4 (e) and 
Appendix (e) for discussion and evidence). 
9 Patient identifiers Use unique patient identifiers, with common IDs or necessary 
cross-walk “keys” to enable the merging of data from multiple 
sources (e.g. medical, pharmacy, mental health) 
9 Provider 
Identifiers 
Use unique provider identifiers and provider practice specialty 
type indicators – level 2 and 3 HIPAA defined taxonomy codes 
v. 4.1.   For providers with more than one specialty or sub-
specialties, a primary specialty should be defined, which 
represents the primary or major practice specialty type.  
9 Provider practice, 
group and other 
network and 
system affiliations 
Practice group identifiers, affiliation codes and tax id numbers 
should be used to roll up individual provider measures.  
Preference is to measure providers on an individual basis and to 
maintain the flexibility to roll up the data to the group level. 
9 Plan medical 
claims data sources 
Facility - UB-92, HCPCS, ICD-9 
Professional & Ancillary providers – HCFA 1500, HCPCS, 
CPT-4, ICD-9  
9 Plan pharmacy 
data sources 
NDC 
9 Lab data sources UB-92, HCPCS, ICD-9, CPT-4 
9 Radiology & other 
diagnostic data 
sources 
UB-92, HCPCS, CPT-4, ICD-9, NDC 
9 MH/SA & other 
carve out data 
sources 
UB-92, HCPCS, CPT-4, ICD-9, NDC 
9 Medicare data 
sources 
UB-92, HCPCS, CPT-4, ICD-9, NDC 
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Application Rule 
Sets/Required 
Statistical 
Adjustments: 
The primary unit of measure is the full longitudinal episode 
of care, comprised of all inputs associated with treating a 
patient with a specific disease or condition over time. 
Whenever possible, claims experience should be adjusted to 
reflect the relative severity of illness of the patient and the 
complexity of the case. 
In general, claims experience should be grouped into 
episodes based on standard ICD-9 and CPT-4 diagnosis and 
procedure codes, and, in most cases, episodes for chronic 
conditions should include at least one full year of claims 
activity. Episode groupings should be for homogenous 
medical conditions and severity levels. Therefore claims 
whose diagnosis or procedure codes are not the direct result 
of treating a specific disease or condition should be 
segregated and grouped within another relevant episode of 
care. Consideration should be given to the presence of co-
morbid conditions or clinically related conditions that can 
cause “normal” complications, which may have an impact 
on treatment patterns and case complexity (e.g. hemophilia 
and broken leg).  
9 Resource Based Actual and standardized unit price reimbursement rates should 
be used, prior to application of beneficiary liability rules 
(allowed amounts).  Standardized unit pricing (e.g. AWP, 
Medicare fee schedules) should be used to enable isolation of 
utilization variance from unit price variance whenever possible. 
9 Case mix, volume, 
and severity 
adjustments 
Measures should be adjusted for the nature and volume of the 
types of diseases/conditions comprising a providers’ episode 
experience, and peer comparisons should adjust for case mix. 
Internally developed or applicable third party weights may be 
applied, which reflect population composition (e.g. commercial, 
Medicare, Medicaid). Typically episode groupers organize 
cases together based on their similarity with respect to the 
medical problem being treated, with some stratification for the 
severity of that problem – they stratify by disease-specific 
morbidity.  However, they may not adjust for co-morbidities, 
thus ignoring the total illness burden of the patient.  As such, it 
is important to include a severity adjustment that will take into 
consideration not just the relative severity of the current illness 
but of the overall health status of the patient. 
9 Use of standard 
reimbursement 
weighting  
RBRVS, DRG, AP-DRG and APR-DRG, ASCs, Per Diems 
based on UB-92 bed type revenue codes, etc. 
9 Accounting for 
inpatient facility 
transfer/admission 
For inpatient hospital measures, apply Medicare regulations and 
associated prorating rules for transfers among facilities and re-
admissions. For complete episodes, method should capture all 
related activity prior to defined clean periods. 
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9 Facility Re-
admissions 
Apply Medicare guidelines for readmissions in accounting for 
length of stay and resource utilization. 
9 Grouping based on 
diagnosis and 
procedure codes 
Use homogeneous clinical groupings of episodes of care.  
Where non-specific or “other” categories exist, further analysis 
may be required, prior to using normative and relative 
efficiency measures. In general, procedure codes should be used 
for grouping when measuring hospital efficiency while 
diagnosis codes should be used when measuring physician 
efficiency.  However, it’s important to note that a significant 
portion of hospital stays do not involve surgery and that, 
conversely, for some specialties – in particular surgeons – the 
procedure defines their involvement. 
9 Identifying 
standard time 
period and 
adjustments for 
chronic conditions 
The common convention is to use a 360-day time window.  
However, longer time periods can also be used. Where possible, 
adjustment for relative severity of illness of such conditions 
may be quantified based on the diagnosis coding and other lab 
and demographic data associated to the patient. 
9 Determining 
exclusions of 
specific 
procedures/proced
ures/cases 
Common exclusions:  
• Transplants: leukemia with bone marrow, heart, lung, 
liver, kidney, etc… 
• Burns w/ & w/out surgery 
• All diseases and conditions mapped to “other” and non-
specific catch all categories. 
9 Accounting for 
total population 
experience in 
severity of illness 
Use emerging population based risk-adjusting methods that 
evaluate groups of patients and their associated episodes of 
care, as opposed to evaluation of each discrete episode. 
Approaches to account for differences in population 
composition and relative risk are desired, but should not mask 
true variation. When using market basket and other 
normalization approaches, data sources and market basket 
composition should be scrutinized to make sure that populations 
are comparable. 
9 Treating of outlier 
observations 
If sufficient episode volume exists from internal data, outlier 
thresholds should be defined for each episode type at 2-2.5 
standard deviations from mean, otherwise reliance on third 
party cut points may be applied.  Total episode experience 
across specialties or within peer group specialties may be used – 
again, case volume should be considered in order to ensure 
representative experience dispersion.  
9 Recognition of 
start and finish for 
acute conditions 
Fragmented and incomplete episodes should be removed from 
analyses.  Clean period durations are condition specific. 
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Data Output/ 
Generating Valid 
Information: 
Episodes are first routinely attributed to the treating 
physician whose professional claims makes up the highest 
percentage of professional claims within an episode, and 
whose total claims costs account for at least 25% of the total 
“eligible clinician” claims (in dollar terms). Providers that 
are not responsible for the direct management of treatment, 
such as radiologist, anesthesiologists, and pathologists, are 
not considered controlling or responsible providers for 
efficiency measurement purposes.  Furthermore, episodes 
can be attributed to all other eligible providers (including 
hospitals) whose total claims account for 25% or more of 
eligible costs within that episode. In this instance a single 
episode is usually not attributed to more than three treating 
providers involved in an episode of care. (See discussion in 
Appendix (d)).  In rarer cases, episodes can be attributed to 
physicians with the most face-to-face encounters. 
In many cases, appropriate peer-to-peer comparisons may 
benefit from adjustments to reflect the mission of a hospital 
(e.g. uninsured) or the socio-economic status of the patient 
mix. (See discussion in Appendix (g)). In all cases, small 
sample sizes increase the risk of misclassifying the provider 
(see Section 4 (c) and Appendix (f) for discussion and 
evidence). 
9 Assignment of 
episodes/patients 
to accountable 
providers 
Attribution rules should be based on providers with the greatest 
amount of activity and/or control over the case (costs and 
encounter activity).  An eligible cost percent threshold 
contained within an episode of care is a generally accepted 
assignment method.   
For assignment of episodes to primary care providers, the level 
of involvement and/or actual control and influence over 
specialist utilization and practice patterns should be taken into 
consideration.   
9 Minimum number 
of episode 
assignments for 
study inclusion 
(See Section 4 (c) 
for Discussion) 
Sufficient case volumes of complete, non-outlier episodes per 
clinician or hospital should be used, and users should disclose 
the case volumes, the significance level attained, and the risk of 
misclassification for each provider that is measured.  The 
general rule for assuring a high level of statistical significance is 
to maximize episode volume where possible, which may require 
combining data from multiple sources.  Variability within 
episode types may fluctuate materially. As such, the nature and 
volume of episodes attributed to a provider should be assessed 
in establishing credible sample size requirements.  Ongoing 
research is expected to generate more precise guidelines on 
minimum case volumes.   
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Current empirical evidence suggests that sample sizes of 100 or 
more episodes (and at least 19 other physicians of the same 
specialty type in the comparison group to allow for a valid 
comparison) provide reliable physician performance indicators; 
and sample sizes of 30 or more procedure-specific episodes 
(and a total of at least 100 procedure-specific episodes across 
hospitals in the comparison group) provide reliable hospital 
performance indicators. 
9 Recognition and 
treatment of unit 
price variance and 
measurement of 
utilization 
Cost measures are comprised of both unit price and utilization 
of services in the treatment of a disease or condition.  Both 
elements should be isolated, in order to understand the cause of 
performance variance, to educate providers as to where 
performance improvements may be realized and to quantify the 
total potential improvement opportunity over time. 
9 Peer to peer 
comparisons  
Practice patterns and provider performance evaluation should be 
completed on a provider practice specialty basis.  Over time, as 
standards of care and improved methods for determining 
medical appropriateness are developed, cross specialty 
comparisons may be possible.  
9 Where appropriate 
allowances for 
provider mission 
(i.e. DSH) should 
be assessed and 
applied 
Consideration should be given to the nature of 
diseases/conditions and populations being served that may 
result in appropriate adjustment to performance measures (e.g. 
academic medical centers, specialty hospitals, etc.). Appendix 
(g) contains a discussion of the research being conducted to 
determine the validity of this adjustment when using a price-
sensitive efficiency index.  For high volume “common” 
treatments, such as normal deliveries or appendectomies, 
adjustments may not be warranted.  They are not warranted 
either when using a resource based efficiency index (i.e. one 
that excludes price). 
9 Normative v. 
straight scale 
standards 
Variability relative to peer group norms should be used (grade 
on curve).  Over time, as standards of care and appropriateness 
are more readily measured using administrative data, straight 
scale performance measures may be applied. 
Quality indicators and compliance with evidence based 
medicine guidelines are more readily measured on an 
established scale.   
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4) Discussion 
 
Measurement entails comparisons, and comparisons lead to differentiation, and 
that’s always uncomfortable for those that are being compared.  In today’s environment, 
comparisons have ramifications on income, and that creates an even greater demand for 
the best possible rigor to be applied in the measurement effort. 
 
Almost universally, when asked what is most important in designing measures, 
those being measured will respond that the measures (or measurement system) must be 
fair, lead to valid conclusions, and create an actionable result.  As this Paper has already 
described, multiple stakeholders put these same attributes forth, and that is what has 
guided our recommendations. 
 
During the process of outlining these recommendations, the team had many 
discussions during which the advantages and disadvantages of any individual 
recommendation were advanced and debated. Below are the results of a few of those 
discussions, and we invite readers of this paper to continue the discussion at 
www.regence.com/research:  
  
a) Limitations on Individual and Group Measurement  
 Limitations in measurement at both the individual and group level should 
be highlighted. In some cases, care is delivered by a group of physicians 
rather than a single physician, and it’s important to understand the 
relationship between the providers and their impact on the patient’s 
outcomes in cost and quality. Conversely, in many cases, measurement at 
the individual level limits the availability of adequate sample sizes, which 
means some metrics may only be measurable on a group level. Of course, 
the major limitation of measuring at the group level is that the more the 
data is rolled up from individuals to group the more you lose in terms of 
finding opportunity for improvement.   
 The more data are aggregated across procedures or across physicians, the 
more the results will have a tendency to cluster around the mean. 
Whenever variation at the provider or procedure level gets masked, 
interpreting the results becomes more challenging, and acting on those 
results very difficult. 
 
b) Limitations on Using Episodes as Basis for Calculating Efficiency 
 Grouping claims into clusters around standard diagnosis and procedure 
codes to form episodes is a common way of comparing the relative level 
of efficiency from one provider to another. However, since procedures 
inherently reflect higher resource utilization, the severity of the episode 
may be inappropriately weighted higher and, post severity-adjustment, 
inadvertently rate a physician more efficient when the procedure may not 
have been indicated or inappropriately used.  For example, a physician 
who performs a high rate of procedures may be ranked as more efficient, 
after severity adjustment, when, in fact, that physician may represent less 
efficient practice patterns by performing more procedures than otherwise 
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appropriate. Removing procedures from the definition of episodes that 
measure physician efficiency will alleviate this issue. 
 Since there is an ex ante assumption that delivering the episode is 
appropriate, any analysis should use national (or other “best-in-class”) 
benchmarks to compare not only the relative level of efficiency, but also 
the average quantity of episodes.  Health Plans, as a matter of normal 
network management, should be aware of this limitation and understand 
how to minimize its impact, in particular by always grouping cases that 
are clinically similar. 
 However, it is appropriate to measure hospital efficiency using procedures 
as the central event around which other claims are grouped into episodes, 
understanding that external benchmarks should also be used to determine 
the overall appropriateness of the rate of procedures performed.  
Information from the Dartmouth Atlas should be particularly useful in that 
respect. 
 Over the years, episodes are not the only way health plans have measured 
provider performance.  In fact, population-based metrics were more the 
norm before the introduction of solid episode-based methodologies and 
continue to be used. An episode of care approach is an important 
component of any performance measurement strategy.  This is particularly 
true for assessing specialist performance and the performance of PCPs in 
non-gatekeeper model insurance products (where the PCP role is not 
administratively assigned).  However, this recommendation completely 
ignores the potential value of a population-based approach to efficiency, 
where a provider is assessed using the experience of their entire 
population of patients – not just the patients who required care and 
triggered one or more episodes.  Such a population-based approach is most 
useful for assessing PCP performance, where performance for treating a 
panel of patients is compared.  In addition, it could have use when 
comparing health systems and different components of networks, where 
total population experience has importance.  
 In general, a population-based approach would involve PMPM or 
utilization per 1,000 type measures and use population-based rather than 
episode-based risk adjusters.  Population-based risk adjusters used most 
widely in the industry for measuring provider performance include (in 
alphabetical order) -- Adjusted Clinical Groups (ACGs), Diagnostic Cost 
Groups (DCGs), and Episode Risk Groups (ERGs). 
 Population-based measures do have some advantages, including 
measuring overall performance for a population – not just patients with 
one or more episodes.  A provider that keeps their population generally 
healthy, where acute and some chronic care is only initiated when the 
patient is relatively sick, could experience more costly episodes, on 
average. 
 A related point is the use of population-based measures for patients with 
systemic, chronic conditions such as diabetes.  Assessing how well a 
provider manages the overall care of these patients – on a population basis 
– has some value.  
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c) Limitations on Sample Size & Age of Data 
 The empirical analysis contained in this Paper, as well as work done by 
other statisticians, continues to point to the need for large sample sizes in 
analyzing provider efficiency. The confidence interval around the scores 
created with small sample sizes is large.  As a result, only significant 
outliers can be identified, with all others arrayed around the mean.  
However, most health plans or third party administrators will find it 
difficult to accumulate enough valid episodes to meet the sample size 
requirements for all their providers, thus decreasing their ability to 
measure efficiency. 
 In general, the threshold will depend on two factors: (1) some asymptotic 
relationship between sample size and standard error – at what point does 
additional sample size produce only a modest increase in precision, and 
(2) the “taste” for variation – what confidence interval size is acceptable to 
all parties involved in the measurement exercise. 
 There are two strategies that plans can adopt to mitigate small sample 
sizes.  The first is to only measure the providers that it can.  By definition, 
these will be a plan’s top volume providers, those that see the majority of 
the plan’s members, and therefore those whose performance it is most 
important to measure. However, plans using this strategy should find 
external benchmarks against which to assess the relative performance of 
their providers to ensure that providers deemed efficient are, in fact, 
efficient. 
The second strategy is to pool data across payers.  There are a number of 
initiatives of this type that are being developed around the country and that 
offer all the plans an equal ability to measure the relative level of 
efficiency of all their network providers. 
 There is another option available, namely to go back in time as far as 
needed to accumulate the necessary amount of episodes to reach the 
minimum sample size.  There is a risk in doing so of missing any 
improvements that the provider may have realized more recently, and it 
also creates a risk of lack of comparability – based on changes in service 
pricing (contracts and fee schedules) and changes in technology. 
 
d) Limitations on any Single Methodology 
 Using any episode-based methodology alone to calculate efficiency will 
have limitations because of its design.  For example, and as discussed 
above, calculating a physician or group’s overall efficiency would likely 
require more of a population based comparison as opposed to an 
individual episode comparison.  Similarly DCGs, which are widely used 
by Medicare, are more appropriate to establish a population based case 
mix risk classification. 
 Comprehensive analyses of provider efficiency at different levels of the 
value chain require different sets of tools to be applied appropriately, and 
most likely a combination of tools. 
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e) Limitations on using Medical Claims only 
 Some physician efficiency performance measures may be materially 
impacted by inclusion/exclusion of pharmacy claims experience.   
 Some empirical evidence suggests that, in a commercially insured 
population, the range in variation and the number of providers whose 
performance measures change from efficient to inefficient/inefficient to 
efficient can be significant when analyzing data using one common 
method.  However, further analysis and research is needed to determine if 
this finding holds true using different methodology, or on different types 
of populations (i.e. Medicare). 
 The magnitude of variance and impact on efficiency results appears to 
affect all provider specialty types, though to varying degrees, although 
more research is needed to determine the magnitude of the impact when 
using different minimum number of episodes assigned to each provider. 
 Commercial carriers should rely on efficiency measures that include both 
medical and pharmacy claims experience whenever possible.  “False 
positives and negatives” may result from efficiency analyses that exclude 
pharmacy experience.  
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5)  Appendices 
a) About the Processes 
i) Design for Six Sigma (DFSS) 
ii) Quality Functional Deployment (QFD) 
b) About the Sponsors and Supporters of this Effort 
c) About the Multi-Stakeholder Team 
i) Stakeholder Representation 
ii) Member Biographies and Affiliations 
d) About Attribution Rules 
i) Advantages and Disadvantages of Various Methods 
ii) Analysis of Impact of % Claims Threshold on Attribution 
e) About Pharmacy Data 
i) Analysis of Impact of Inclusion or Exclusion of Pharmacy Data 
ii) Conclusions and Implications 
f) About Sample Sizes 
i) Analysis of Impact of Sample Sizes on Reliability of Measure 
ii) Conclusions and Implications 
g) About Hospital Mission Adjustments 
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a) About the Processes 
i) Design for Six Sigma (DFSS) 
 
The DFSS process lays out a series of steps, grouped in Tollgates, and statistical tools that guide 
the development of a new product or service.  Unique concepts in Six Sigma are CTQs – program 
attributes that are Critical-To-Quality and define what the customer needs – and CTPs – design 
attributes of the product or service that are Critical-To-Process and will ensure that CTQs are met. 
The application of these concepts increases the likelihood of success of new products or services. 
 
DFSS Process 
 
When designing new “products” or “services” using DFSS, the designers need to clearly 
define customers and stakeholders, understanding that customers are the primary 
beneficiaries of the product while stakeholders may be impacted by its introduction. This 
distinction is important as customer needs will supersede stakeholder needs in the event a 
design element would create a conflict between fulfilling a customer or stakeholder need. 
Customers: 
• Purchasers and Insurers: Who bear most of the near term economic costs from 
inefficiency and poor quality 
• Consumers: Who bear most of the long term economic costs of inefficiency and 
the tangible suffering from poor quality 
Stakeholders: 
• Providers: Who want actionable information and deserve validity in rankings 
• Accreditors: Who deserve wider support for their provider assessments 
• Benefits Consultants: Who need to be able to identify most valid provider 
assessment methods 
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Customer Needs: 
Health plans stated that efficiency measures must be operational and feasible 
to implement and able to be incorporated into existing processes and systems. 
In addition plans articulated challenges of data collection, in particular the costs 
of collecting chart data, which need to be addressed.  However, they also felt that 
the principles should be validated, specific, measurable, and actionable. To the 
extent possible, measures of care efficiency and effectiveness should recognize a 
plan’s ability to help manage patient care. Finally, methods used in measuring 
efficiency should be fair to plans of all sizes.  
Purchasers need measures to be validated and standardized to enable valid 
comparisons across plans and networks. Efficiency has to reflect the overall 
cost of providing care services to a patient over time. Efficiency measures should 
be married to quality measurement to avoid sacrificing one for the other. 
Measures have to provide the greatest possible impact, be feasible and enable 
fair, reliable and reproducible evaluation of providers, plans and networks. The 
measures must be adoptable by all plans without increasing plan-related costs.  
Consumers want information that is: credible, reliable, understandable, 
actionable, expert-based, timely and easy to access. Consumers want their plan 
sponsor to act as an information hub, giving them the knowledge to make 
informed choices. Consumers want an employer or plan to remind them 
periodically about where they can find the information they need. Consumers 
want access to providers of their choice, even if these providers are not of high 
quality.  
 
Stakeholder Needs: 
Providers want any methods used in measuring efficiency to be valid, fair 
and equitable when reflecting performance, differentiating between unit 
price and resource use/practice pattern, mindful of patient health status, 
sample sizes and appropriateness of peer-to-peer comparisons. The measures 
have to provide valid comparisons to help evaluate a physician or medical group 
practice and differentiate it from others when the data shows meaningful 
differences. Performance measures have to enable greater efficiency and an 
associated increase in the bottom line. Measures have to recognize creativity, 
leadership and organizational effectiveness. Finally, measures should not create 
a burden on office or staff, or create conflicts with patients.   
Accreditors want the adoption of scientifically valid methods in formulating 
measures. Measures should have a reasonable scoring methodology, as well as 
result in wide provider, purchaser and plan support to adopt these methods in 
future accreditation.  
Benefits consultants want consistent methodology that is applied industry 
wide for measuring provider performance. They also want the methodology to 
allow for aggregation of results among health plans. Rules should be objective 
with neutral measures, which mitigate “gaming” risk by providers and payors. 
Finally, efficiency analyses, which are based today mainly on administrative data, 
should evolve over time to include meaningful clinical data from patients’ 
medical records. 
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Once identified, needs are converted into CTQs that are used to design specific processes 
or product attributes that will meet all stakeholder requirements. Some of the processes 
become CTPs as any error they produce will result in a significant negative impact on the 
customers. 
 
CTQs: 
Operational and feasible Data collection and implementation of the methodologies 
have to be operational and feasible for plans and providers, 
without creating undue burden on staff or resources 
Fair (methods) The methods used in calculating efficiency and the 
application of those methods should be transparent, reflect 
the overall cost of care, locus of control (e.g. providers 
should not be held accountable for the impact of benefit 
design/cost-sharing), allow for appropriate risk-adjustment, 
peer-to-peer comparisons, the right weighting of unit price 
v. resource use, account for the value of care coordination 
and other care management processes 
Equitable (ranking) The scoring of the variables and the providers should be 
reasonable, avoid gaming by any party, and lead to shared 
savings among purchasers/plans, providers and consumers 
Credible and reliable All methods used and their output should be sound, 
evidence-based, empirically valid, timely and informed by 
experts 
Actionable The output from the methodology should be actionable by 
either plans and/or providers, enabling them to understand 
opportunities for improvement and their relative 
performance compared to others 
 
 
ii) Quality Functional Deployment (QFD) 
 
CTQs are extensively used to identify key product requirements that will meet customer 
needs. Quality Functional Deployment or QFD is a DFSS tool used to identify these 
product requirements.  In this project the team created six QFDs to identify the product 
requirements for physicians and hospitals, separately, in each of the three areas of focus: 
Data Input, Application Rule Sets, and Data Output. Each team member was asked to fill 
out the six QFDs, reaching out to the stakeholder they represented and gathering input 
from them.  The results were then consolidated to yield a consensus-based set.  During 
that consolidation process, team members articulated the views of their stakeholders and 
explained their rationale for rating a requirement as having a High, Medium, or Low 
impact on a program attribute. 
 
All requirements were then ranked in order of overall importance and the requirements 
that had the most impact were kept by the team, and those are the ones for which 
recommendations were specified. 
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Below is an example of a consolidated QFD for Data Input to measure physician 
efficiency. 
Customer Expectation 
Im
po
rta
nc
e 
 
P
la
n-
sp
ec
ifi
c 
da
ta
 - 
m
ed
ic
al
 
P
la
n-
sp
ec
ifi
c 
da
ta
 - 
ph
ar
m
ac
y 
La
b 
da
ta
 
P
la
n-
sp
ec
ifi
c 
da
ta
 - 
M
H
S
A
 &
 o
th
er
 c
ar
ve
-o
ut
s 
 
O
th
er
 d
at
a 
--
 M
ed
ic
ar
e 
(w
/ p
at
ie
nt
 ID
) 
ra
di
ol
og
y 
an
d 
ot
he
r d
ia
gn
os
tic
 d
at
a 
 
P
at
ie
nt
-r
ep
or
te
d 
H
ea
lth
 S
ta
tu
s 
S
oc
io
-d
em
og
ra
ph
ic
 d
at
a 
 
O
th
er
 d
at
a 
- s
ta
te
 d
at
a 
ba
se
s 
O
th
er
 d
at
a 
- t
hi
rd
 p
ar
ty
 c
om
m
er
ci
al
 v
en
do
rs
  
  
To
ta
l 
actionable 5 H H H H H H M M L L   310
credible & reliable 4 M M M M M M L M L L   96
fair 4 H H H H H H H M M L   280
operational & feasible 4 H M M L L L M M L L   104
equitable 3 H H H H H H H H L L   222
                 
Total   156 132 132 124 124 124 94 78 28 20     
 
 
All requirements that scored a total of more than 100 points were kept and have 
recommendations. The summary of requirements and associated scores, out of a total 
potential score of 180, are: 
 
Data Input: 
Hospitals 
1. Plan-specific data - medical claims (split price & use) – 132 
2. Lab data - 118 
3. Radiology and other diagnostic data - 118  
4. Other data -- Medicare - 108 
 
Physicians 
1. Plan-specific data – Medical claims (split price & use) – 156 
2. Plan-specific data – pharmacy - 132 
3. Lab data - 132 
4. Plan-specific data - MHSA & other carve-outs - 124 
5. Other data -- Medicare (w/ unique ID) - 124 
6. Radiology and other diagnostic data - 124 
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Application Rule Sets: 
Hospitals 
1. Resource-based case-mix indices (CMI) & adjustments –180 
2. Use of standard DRG weights - 180 
3. Accounts for readmissions - 180 
4. Grouping based on diagnosis & procedure codes (e.g. DRG) - 156 
5. Exclusions (Specific procedures always excluded) - 150 
6. Treatment of outliers (relative cost, duration, standard deviation and 
variance limits, etc…) - 126 
7. Total population experience in severity of illness - 126 
 
Physicians 
1. Resource-based case-mix indices (CMI) & adjustments – 180 
2. Use of standard DRG/ASC weights - 180 
3. Grouping based on diagnosis or procedure (ICD-9, CPT) - 156 
4. Standard time period & overall resource use definitions for chronic 
conditions - 156 
5. Exclusions of specific conditions/procedures/cases - 150 
6. Total population experience in severity of illness - 150 
7. Treatment of outliers (relative cost, duration, standard deviation and 
variance limits, etc…) - 126  
8. Recognition of “start” and “finish” for acute conditions - 114 
 
Data Output: 
Hospitals 
1. Assignment of patients to accountable providers – 180 
a. Handling of providers w/ insufficient number of assignments - 108 
2. Minimum number of assignments for study inclusion - 180  
3. Recognition and treatment of unit price variance, and measurement of 
utilization - 180 
4. Peer groups, including appropriate allowances for provider mission (i.e. 
DSH hospital) - 180 
5. Normative v. straight scale standards - 180 
6. Trending rules for performance improvement  - 148 
7. Definition of provider specialty types and “master” files - 102 
 
Physicians 
1. Assignment of patients to accountable providers – 180 
a. Handling of providers w/ insufficient number of assignments - 108 
b. Determination of efficiency by practice/entity or larger group - 108 
2. Minimum number of assignments for study inclusion - 180 
3. Recognition and treatment of unit price variance, and measurement of 
utilization - 180 
4. Peer groups, including appropriate allowances for provider mission (i.e. 
DSH hospital) - 180 
5. Normative v. straight scale standards - 180 
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6. Trending rules for performance improvement - 148 
7. Definition of provider specialty types and “master” files - 102 
 
The relative importance of the requirements outlined above underscores the importance 
of the third step in current methods of measuring provider efficiency: the data output, or 
ability to generate valid information.  As such, the recommendations made in this area are 
considered to be the strongest, and need to be applied as closely as possible by payers and 
purchasers to ensure that results are valid. 
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b) About the Sponsors and Supporters of this Effort 
 
i)  The Leapfrog Group: 
 
The Leapfrog Group is an initiative driven by organizations that buy health care who are 
working to initiate breakthrough improvements in the safety, quality and affordability of 
healthcare for Americans. It is a voluntary program aimed at mobilizing employer 
purchasing power to alert America’s health industry that big leaps in health care safety, 
quality and customer value will be recognized and rewarded. 
 
 
ii)  Bridges To Excellence: 
 
Bridges to Excellence is a not-for-profit organization with a Board composed of 
representatives from employers, providers and plans. The Corporation is not formed for 
pecuniary profit or financial gain. The Corporation is organized to create significant 
advances in the quality of health care by: 
1. Providing tools, information and support to consumers of health care services,  
2. Conducting research with respect to existing health care provider reimbursement 
models,  
3. Developing reimbursement models that encourage the recognition of health care 
providers who demonstrate that they have implemented comprehensive solutions 
in the management of patients and deliver safe, timely, effective, efficient, 
equitable and patient-centered care, which is based on adherence to quality 
guidelines and outcomes achievement.  
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c)  About the Multi-Stakeholder Team 
i) Stakeholder Representation 
 
Physicians and representatives of provider organizations, health plans, purchasers, benefit 
consultants, Accreditors, and subject matter experts were all represented in this effort. On 
the core team (with members listed below) stakeholder representatives were tasked to 
consistently and continuously seek input from their peers to gather as broad a base of 
comments and perspectives as possible. Consumers were not directly represented in this 
effort, nor were consumers sought for input on the recommendations contained in this 
paper due to its highly technical nature.  However, consumer input was brought in based 
on prior research conducted by several team members. 
 
ii) Member Biographies and Affiliations 
 
Mark Rattray, MD, is Vice President of The Regence Group and Chief Medical Officer 
for Regence BlueShield, a 1.1 million-member health plan in Washington State.  His 
previous activities include Regional Medical Director for PacifiCare of California, 
clinical informatics development at CareScience, Inc., and a six year career with Health 
Net, Inc. as medical director, divisional chief medical officer, and plan president of its 
Washington and Oregon subsidiaries. He is Board Certified in Obstetrics and Gynecology 
and was in private practice for 12 years in the Seattle area. He is a faculty member of the 
University of Washington School of Medicine. 
 
Dr. Rattray serves on NCQA’s Efficiency Measurement Advisory Panel, the National 
Forum on Performance Benchmarking of Physician Offices and Organizations, The 
Leapfrog Group / Bridges to Excellence core team on clinician efficiency and private 
expert panels on clinical performance measurement and improvement.  
 
 
 
Arnold Milstein, MD, is the Medical Director of the Pacific Business Group on Health 
(PBGH) and a Worldwide Partner at Mercer Human Resource Consulting.  PBGH is the 
largest health care purchasers coalition in the U.S. 
 
His work and publications focus on health care purchasing strategy, clinical performance 
measurement, and the psychology of clinical performance improvement.   
 
He co-founded both the Leapfrog Group and the Consumer-Purchaser Disclosure Project.  
He heads performance measurement activities for both initiatives.  Previously a 
Rosenthal Lecturer at the Institute of Medicine, the New England Journal of Medicine’s 
series on employer sponsored health insurance described him as a “pioneer” in efforts to 
advance quality of care. 
 
Educated at Harvard (BA-Economics), Tufts (MD) and UC-Berkeley (MPH-Health 
Services Evaluation and Planning), he is an associate clinical professor at the University 
of California at San Francisco. 
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Ray Herschman is a Senior Consultant and Principal with Mercer Human Resource 
Consulting, in their Health and Group Benefits practice based in Chicago and Cleveland. 
He is Mercer’s national practice leader for consumer driven health care strategy, 
specializing in the areas of eHealth, consumer decision support, provider cost and quality 
profiling and health care public policy.  Ray works with employers, providers and 
carriers to support their efforts in improving service and enhancing the value of employer 
sponsored group healthcare benefits.    
 
Ray has been a guest speaker on the topics of health care market reform, public policy, 
provider performance measurement and the concepts of consumer driven health care for 
the Robert Wood Johnson Foundation, The Center for Health Systems Change, the 
Washington Business Group on Health, the US Chamber of Commerce, CMS and many 
other national health symposiums. 
 
Ray is a graduate of the University of Wisconsin – Madison with a bachelor’s degree in 
Chemistry and a Masters of Science degree in Accounting and Health Care Finance. He 
is currently a research associate at the Harvard Business School and an advisory board 
member at the Case Western Reserve University graduate school of business.  
 
 
 
Joachim Roski, PhD, MPH, serves as Vice-President, Performance Measurement for the 
National Committee for Quality Assurance (NCQA) in Washington, DC. NCQA is a 
private, not-for-profit organization committed to assessing, reporting on and improving 
the quality of health care. Dr. Roski joined NCQA in 2000 and currently oversees the 
organization’s activities pertaining to performance measure development, research, 
analysis, and public and private sector contracting. He currently serves as Principal 
Investigator or co-investigator on several research or demonstration projects in the area of 
health care quality evaluation and provider-level performance measurement. Many of 
these efforts have been funded by the US Department of Health and Human 
Services/Centers for Medicare and Medicaid Services, the Robert-Wood-Johnson 
Foundation, the Commonwealth Fund, the US Agency of Healthcare Quality and 
Research, and others. He is a frequent speaker at national and international conferences 
and is the author of numerous articles in the area of health care quality and health 
improvement. 
 
Prior to joining NCQA, Dr. Roski served as Director of Quality and Performance 
Effectiveness for Allina Health System in Minneapolis, MN and as Research Director in 
the Division of Epidemiology, School of Public Health, University of Minnesota. He has 
served on the Board of Examiners for the Baldrige National Quality Program – US 
Department of Commerce, grant review committees for the US Agency for Healthcare 
Quality and Research, and as a lecturer on health care quality for the US State 
Department. He currently holds an adjunct faculty appointment at the Ludwig-
Maximilian University, Munich, Germany (Department of Public Health).  
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Suzanne Delbanco, PhD, MPH, is the first Executive Director of The Leapfrog Group.  
Founded by the Business Roundtable, The Leapfrog Group's goal is to mobilize employer 
purchasing power to initiate breakthrough improvements in the safety and overall value 
of healthcare for American consumers.  The Group’s growing consortium of more than 
145 Fortune 500 companies and other large private and public health care purchasers 
provides health benefits to more than 34 million Americans, and spends more than $60 
billion on health care annually.  Suzanne is a member of the NCQA Purchaser Advisory 
Council and the National Quality Forum’s Safe Practices Advisory Panel.   
 
Before joining The Leapfrog Group, she was a senior manager at the Pacific Business 
Group on Health where she worked on the Quality Team.  Prior to joining PBGH, 
Suzanne worked on reproductive health policy and the changing healthcare marketplace 
initiative at the Henry J. Kaiser Family Foundation.  She has also consulted on health 
insurance coverage in the temporary employment industry, the first statewide survey in 
California of Medi-Cal beneficiaries, and worked as a community liaison for Kaiser 
Permanente during the establishment of one of California’s first County Organized 
Health Systems.   
 
Suzanne holds a Ph.D. in Public Policy from the Goldman School of Public Policy and a 
M.P.H. from the School of Public Health at the University of California, Berkeley.    
 
 
Kelly Hall plays a dual role in strategic planning and business development for Partners 
HealthCare System, the Boston-based integrated delivery system founded by 
Massachusetts General Hospital and Brigham and Women’s Hospital.  
 
As Director of Strategic Planning for Partners Community Healthcare, Inc. (PCHI), the 
physician network for Partners HealthCare System, she has led a range of strategic 
initiatives aimed at improving the quality and efficiency of health services delivered to 
PCHI patients.  They have ranged from evaluating opportunities in pharmacy 
management, to working with local employers to improve effectiveness and efficiency of 
care, to leading a major collaboration between PCHI and a large health plan with the goal 
of achieving transformational improvements in the way care is delivered to plan 
members.   
 
As Senior Manager in Partners Business Planning, Kelly plays a leadership role in 
identifying and assessing business development opportunities for both Partners hospitals 
and PCHI physicians, including ambulatory ventures and other clinical collaborations.  In 
addition, she plays a key role in formulating provider network development strategy.   
  
Ms. Hall has over 14 years of experience in for-profit and not-for-profit health care 
delivery, with particular emphasis on delivery system development and health system 
strategy.  Prior to joining PCHI, Ms. Hall was the Director of Delivery System 
Development for the Motion Picture and Television Fund in Southern California.  She is 
a member of the New England Society for Healthcare Strategy.    
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Jeff Levin-Scherz is the Chief Medical Officer of Partners Community HealthCare, Inc, 
the division of Partners HealthCare System which owns community physician practices, 
negotiates managed care contracts on behalf of integrated and affiliated hospitals and 
1100 primary care doctors and 4500 specialists, and arranges programs to further clinical 
integration among Partners constituencies. 
 
He was previously a senior consultant with Reden & Anders, a national health care 
consulting and actuarial firm, where he served as clinical lead on clinical, operational, 
analytic and strategic projects for health plans, providers, and employers.  He led the 
Medical Cost Trend Management initiative, and evaluation of return on investment from 
medical management programs.   
 
Prior to that, he was Vice President and Corporate Medical Director at Tufts Health Plan, 
where he led the department responsible for physician utilization management, health 
programs and disease management, and measurement of clinical quality, and co-chaired 
the plan’s Provider Strategy Team.  He spearheaded clinical efforts to control health care 
premium inflation and efforts and overhaul case management.  Previously, he was the 
President of the Mount Auburn Cambridge Independent Practice Association, comprised 
at the time of 350 physicians at three community teaching hospitals caring for 40,000 
patients under managed care contracts. He practiced primary care internal medicine for 
nine years in the Boston area. 
 
Dr. Levin-Scherz is a Clinical Instructor at Harvard Medical School and an Assistant 
Clinical Professor of Public Health and Family Medicine at Tufts University School of 
Medicine.  He is an Adjunct Lecturer at the Harvard School of Public Health, and an 
Associate Medical Director of Tufts Health Care Institute.  He graduated from Boston 
University School of Medicine and completed his residency at Mount Auburn Hospital in 
Cambridge, MA.  He is board certified in Internal Medicine, and a Fellow of the 
American College of Physicians. He completed his MBA at Columbia University. 
 
 
Francois de Brantes, is the Program Leader for various healthcare initiatives in GE’s 
Corporate Health Care department. Francois is responsible for developing the conceptual 
framework and the implementation of key strategic programs, in particular GE's Active 
Consumer strategy. 
 
He attended the University of Paris IX - Dauphine where he earned a Masters in Finance 
and Taxation.  After completing his military service as a platoon leader in a Light 
Cavalry Regiment, he attended the Tuck School of Business Administration at Dartmouth 
College, where he graduated with an MBA. 
 
Upon graduation, he started a small asset management company with a partner, focused 
primarily on real estate.  The business grew to managing a portfolio valued at several 
hundred million dollars and 30 employees.  He subsequently joined McDougall 
Associates, a Marketing Communications firm, as VP of Strategic Initiatives.  In that 
capacity, he became a consultant to GE's Corporate Healthcare team. 
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He was then hired by GE to take a broad role focusing on many strategic initiatives, 
especially creating, connecting and supporting Active Consumers, and defining market 
mechanisms to reward providers for better performance.  As part of this new role, 
Francois launched a nationally recognized program, Bridges To Excellence, which 
received a grant from the Robert Wood Johnson Foundation.  Bridges To Excellence is 
designed to align incentives between patients, providers and purchasers around better 
quality care and the adoption of system of care that will reduce errors in medicine.  He is 
also the leader of the incentives and rewards Lily Pad, a group that is designing pilots 
around the country to create incentives for hospitals to adopt the Leapfrog safe practices.  
In addition Francois is on an advisory committee for CMS’s Doctor Office Quality 
demonstration program, the purpose of which is to design measures to assess high 
performance in physician practices, and is a member of the eHealthInitiative’s Board of 
Directors and Leadership Council.
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d) About Attribution Rules 
i) Advantages and Disadvantages of Various Methods 
 
Method 1: Highest Cost Clinician 
Of the clinician fees within each episode’s total claims activity, the clinician with the 
highest percentage of expenses is assigned responsibility for the total episode. 
 
Advantages Disadvantages 
In all cases, there will only be one provider 
assigned responsibility for an episode, 
therefore mitigating potential “redundancy” in 
accounting for episodes.  For instances where 
two providers have the same expense value, 
the episode can be assigned to either both 
providers or rules can be established to default 
to one of the providers based on provider 
specialty type. Examples include assignment 
if one of the providers is a PCP or basing 
assignment on the combination of the case’s 
major practice category and each provider’s 
specialty type. (Likelihood of exact same 
allowed is negligible.) 
Applies to all product types (although PCP 
rules aren’t useful for PPO products)  
Able to attribute 100% of cases in this manner 
In many instances there are multiple treating 
providers and only one is held accountable for 
all episode activity.  As such, accountability for 
over-all cost may inappropriately be assigned 
to only one influencing provider. 
Likely to attribute to proceduralist – even if 
s/he played little role in the critical decisions 
that led to the expense of the case 
Small incremental billing leads to large 
incremental attribution 
In a case with many billing physicians, total 
expense attributable to individual doctor who 
“owns” the case might be quite small 
Likely to be considered arbitrary and unfair by 
physicians. 
 
Method 2: Clinician’s Expense Percentage Threshold 
Episode responsibility is determined based on establishing a threshold percentage of total 
eligible clinician fees.  For instance, establishing a 30% of total eligible clinician fees 
threshold. 
 
Advantages Disadvantages 
Using a threshold percentage establishes a minimum level 
of involvement requirement and allows for recognition of 
the fact that in some instances there may be more than one 
provider that has significant influence over the course of 
treatment, while avoiding assignment to those providers 
that may have had only a minor role in the treatment 
process. Also, using a percentage parameter allows for 
flexibility, as threshold changes can be made for overall 
analysis or by episode or specialty type. 
Episodes not meeting the threshold should be eliminated 
from subsequent analysis (highly fragmented care ought 
not be assigned exclusively to a single clinician). 
Comparing the number of eliminated episodes with 
attributed episodes may provide a crude indication of 
system-fragmentation. 
Applies to all product types 
If no provider accounts for at least 
30% of total clinician fees within 
the episode, then the episode is 
“unassigned”. The converse is that 
depending on how the results of a 
provider efficiency analysis are 
used, potential redundancy in 
episodes may introduce additional 
analysis requirements. 
Could have more than 1 physician 
who meets 30% threshold, so could 
have redundancy.  
Could have surgeon have total 
account of episode for one event 
rather than physician with most 
number of encounters. 
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Method 2a: Single Clinician with Greatest Share of Professional Costs, with Threshold 
 
Advantages Disadvantages 
“Redundancy problem” (Method 2) is 
avoidable by assigning each eligible episode 
to one and only one clinician  
Episodes with “ties” are eliminated, as are 
those without any above-threshold clinicians 
Applies to all product types 
Does not incorporate all cases (some will 
remain unassigned due to threshold)  
May exclude a significant layer of a 
physician’s cases 
May significantly reduce the number of cases 
that can be attributed to a physician and reduce 
the total number of physicians that can be 
measured 
 
Method 3: PCP and Specialist Assignment 
For HMO and POS plans that require members to select a primary care provider, episode 
assignment would be based on either method one or two above and the episodes would be 
assigned to the members PCP, regardless of whether the PCP had any claims activity 
within the episode. 
 
Advantages Disadvantages 
Accountability for all episodes is at a 
minimum assigned to PCPs.  The theory that 
primary care providers should or do have 
control over their patients’ over-all care 
continues to be debated, even with the 
significant shift to open access HMOs and 
PPOs and migration away from gatekeeper 
models.  Monitoring patient specialist referral 
flow presents an opportunity to effect change 
by educating PCPs of the variability in 
specialty efficiency and the opportunity to 
provide evidence-based decision support to 
PCPs for managing referrals based on 
specialist effectiveness and efficiency in 
treating specific conditions. Also, assignment 
of all episodes to PCPs creates awareness of 
all care being provided to his/her patients and 
may lead to more coordination of care and 
reducing potential conflicts or adverse 
outcomes. 
PCPs have resisted being accountable for how 
specialist provide and manage care.  Also, in a 
fee for service environment, PCPs are not 
compensated for managing and monitoring the 
activity of other providers, nor is there a 
financial incentive to do so. 
Automatic attribution to the panel PCP runs the 
risk of measuring administrative compliance in 
addition to (and/or rather than) physician 
performance. 
Assigning an episode to multiple providers 
increases the difficulty of explanation and 
subsequent analyses. 
Might encourage PCPs to “chase away” 
complicated people – just the folks who would 
most benefit from the coordination the PCP 
could provide.  
Likely to disadvantage PCPs with generally 
sicker panels, as risk adjustment tends to under 
adjust at the high and low extremes of severity. 
Applies to only some product types 
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Method 4: Virtual PCPs/Specialists 
For non-gate keeper models, the assignment to primary care providers either involved in 
an episode, regardless of the percentage of clinician fees, or based on over-all historical 
claims history, where a PCP visit has been identified for that patient over a defined period 
of time, i.e. over the 12 months prior to the episode beginning date. 
 
Advantages Disadvantages 
Allows more cases to be attributed. 
Forces a degree of accountability even when 
the PCP mainly farms out cases 
Automatic attribution to an inferred PCP might 
merely provide a “virtual panel snapshot” 
rather than gauging physician performance. 
Might discourage PCPs from being willing to 
care for patients with multi-system disease. 
Applies to only some product types 
 
Method 5: Assignment to All Involved Clinicians 
For every provider involved in every episode, the provider is assigned responsibility for 
each episode.  The idea behind this approach is that there will never be an instance where 
a provider is not measured, based on all their activity. 
 
Advantages Disadvantages 
All providers will be “accountable” for all 
cases they are involved with. 
Concept bears some resemblance to Health 
Benchmarks’ “patient-centered, team-based” 
case assignment method, in which all active 
clinicians receive credit for the compliant 
actions of at least one colleague. 
Might be appropriate within large, closed 
group practices, where sharing episode credit 
with colleagues is less threatening than with 
external, competing clinicians. Of course, in 
such a practice a group rating would probably 
be more appropriate anyway. 
Applies to all product types 
Providers that have no true influence or control 
for the overall episode are held somewhat 
accountable for that episode.  More data 
analysis would be warranted for understanding 
any results.  Providers are less comfortable 
with being “accountable” for cases they have 
minimal involvement. 
Challenges clinicians’ sense of practice 
autonomy, and therefore can be hard to sell to 
clinicians, particularly in groups 
Assigning an episode to multiple providers 
increases the difficulty of explanation and 
subsequent analyses. 
A variation of this method involves assigning 
portions of a single episode to each 
participating clinician. Implications for 
subsequent analysis not yet clear. 
Difficult to justify the fact that there would be 
no substantial difference between attribution 
for a physician who covers for one weekend 
and physician who cares for patient long-term. 
This might be more appealing if there was 
some reasonable threshold applied. 
Could theoretically discourage physicians from 
making themselves available to care for 
difficult patients.  
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Method 6: Major Procedure Provider 
For cases where a “significant” procedure occurs within the case, such as of an inpatient 
surgical case e.g. hip replacement or appendectomy, the provider that renders the service 
is assigned responsibility for the episode, regardless of the level of involvement of other 
clinicians.  The idea behind this approach is that based on the nature of the procedure, a 
specific individual provider is in control of and therefore fully responsible for the entire 
episode. 
 
Advantages Disadvantages 
A single “accountable” provider is established 
for all such cases. 
Applies to all product types 
Only applies to surgical episode types. Also 
requires that for each type of surgical episode, 
that logic be developed to recognize the 
eligible cases and specific procedures are 
identified for provider assignment. In some 
cases, providers may be held accountable for a 
case that other providers may have direct 
influence over how the case was treated and 
whether surgical procedures were warranted. 
Usually, major procedures dominate episode 
professional costs.  This approach may already 
be represented in Methods 1 and 2. 
 
Method 7: Most Face-to-Face Encounters 
 
Advantages Disadvantages 
Avoids using dollars, which can be influenced 
by contracting differences 
Eligible E&M codes can be tailored to 
include/exclude/weight emergency room, 
hospital rounding, nursing home and office 
visits. 
Single-procedure but costly surgical episodes 
could still be assigned to primary care 
clinicians, making referral decisions more 
critical to efficiency scores. 
Applies to all product types 
Single-procedure but costly surgical episodes 
may still be assigned to primary care clinician, 
reducing episode volume for evaluating 
surgical specialty efficiency. As a practical 
matter, little ranking of surgical specialists will 
be possible with this method. 
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ii) Analysis of Impact of % Claims Threshold on Attribution 
 
The data table below addresses the following question: What happens to the amount of 
data left for analysis when a single aspect of an attribution rule is altered?  That aspect is 
the minimum portion of total professional dollars in the episode required to be delivered 
by the attributed clinician.  Each column in the table, from 0% to 100% in increments of 
10%, represents a separate application of the attribution rule.  A host of descriptive 
statistics appear in each column to characterize the retained data; that is, the episodic and 
attributed data that would be available for clinician analysis. 
 
 
 
 
 
One important finding is that very little data is lost as the threshold changes from 0% to 
30%, whether we consider episode volume, number of attributed clinicians, or total 
dollars.  In this large sample of commercial claims, more than 88% of all episodes 
featured only one clinician eligible to be the attributed clinician (see the 100% column in 
the data table).  This seems to suggest that the episode-grouping tool is effective at 
breaking apart a whole patient’s constellation of conditions and diseases into discrete, 
individually attributable events. 
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The following chart, derived from figures in the data table, attempts to show both the 
scale and composition of retained dollars under various attribution scenarios.  The 
declining height of each stacked column (left-to-right) indicates the rate of data loss in 
dollars as the minimum threshold is increased.  The percentages within each stacked 
column segment give the share of service dollars associated with the attributed clinician, 
other clinicians, and all providers.  Again, the percentage splits and total height are 
relatively stable across the 0% to 30% threshold range. Note that some episodes have no 
professional involvement, and are impossible to attribute (leftmost column). 
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The final chart below presents essentially the same information from the chart above, but 
in "per episode" terms. 
 
 
Version 1.0 12-31-2004 Page 45 of 51 
All rights reserved, The Leapfrog Group, Bridges To Excellence   
e) About Pharmacy Data 
i) Analysis of Impact of Inclusion or Exclusion of Pharmacy Data 
 
While this is an area that requires much more research before making broad-
based conclusions, there is some empirical evidence that suggests that 
including pharmacy data has an impact on the efficiency score given to a 
physician.  The research study described below was performed on a 
commercially insured population.  Since the results were not compared to 
actual physician performance, the conclusions mainly focus on the potential 
for misclassification when pharmacy data are excluded, to the extent they are 
available. 
 
Study Design: 
Efficiency performance measures were completed for 2,728 unique providers, 
across multiple specialty types, for members with both medical and pharmacy 
claims experience.  
 Efficiency performance measures were completed for the same 2,728 
providers, using the same medical claims experience, excluding pharmacy 
experience.  
 Using the medical + pharmacy based performance scores, providers were 
segregated into efficient (<1) and inefficient (>1), regardless of whether or 
not they were different from the mean.  Providers were then categorized 
into efficient and inefficient based on medical only performance scores.   
 Variances in provider status were analyzed by analyzing the number of 
providers that changed status (efficient to inefficient and inefficient to 
efficient. 
 Compute the percentage change in performance scores of all providers 
 We chose to examine all providers that had at least 30 complete non-
outlier episodes, reflecting the current average level of episodes that are 
routinely used by payers in measuring provider efficiency.    
 Episodes were attributed to providers who had the highest professional 
claims within an episode, exceeding a minimum threshold for 25% of 
eligible clinician fees (eligible clinician fees included all professional fees, 
excluding hospital based physicians). 
 Expected episode costs were based on peer group norms for each episode 
treatment group. 
 Efficiency performance indices were based on the variance between actual 
and expected episode costs, on a weighted average, case mix adjusted 
basis. 
 
ii) Conclusions and Implications: 
 Some provider efficiency performance measures may be materially 
impacted by inclusion/exclusion of pharmacy claims experience. 
 It is not known whether these findings would be replicated when using 
larger minimum number of episodes   
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 The range in variation and the number of providers whose performance 
measures change from efficient to inefficient/inefficient to efficient is 
significant. 
 The magnitude of variance and impact on efficiency results appears to 
affect all provider specialty types. 
 Whenever possible, carriers should rely on efficiency measures that 
include both medical and pharmacy claims experience.  “False positives 
and negatives” may result from efficiency analyses that exclude pharmacy 
experience.  
 Further analysis is warranted to assess the impact on a condition specific 
basis, on different population types, and using different methodologies for 
assessing provider efficiency. 
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f)  About Sample Sizes 
i) Analysis of Impact of Sample Sizes on Reliability of Measure 
 
Study Design: 
 We began by selecting 5 specialties to study.  These are specialties that are 
frequently profiled and tend to comprise a significant amount of the health care 
experience, both in terms of dollars and episodes. 
o Cardiovascular Disease  
o Internal Medicine 
o Obstetrics/Gynecology 
o Orthopedic Surgery 
o Pediatrics 
 Within each of the 5 specialties, we randomly selected 10 physicians to study 
from the subset of physicians with at least 100 episodes overall. 
 The experience that we relied on covers episodes incurred from 2001 through 
2003 (36 months) by members residing in Northeast Ohio. 
 We chose to examine the changes in performance score for each physician at 5 
different thresholds: 
o n = 20 episodes of care overall 
o n = 30 
o n = 50 
o n = 75 
o n = 100 
 For each n, a random number generator selected the n episodes from the pool of 
actual episodes.  The only episodes that were considered for the study were both 
complete/full-year and non-outlier.  After selecting the n episodes, a new 
performance score was calculated (PI=actual $ /expected $).  This process was 
repeated 200 times for each n, for each provider. 
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ii) Conclusions and Implications: 
 
 The volume of episodes used in determining a provider’s episodic 
efficiency has a significant impact on the overall credibility of the 
resulting performance index (PI). 
 Conventional sample size thresholds currently being utilized may result in 
inappropriate classification of a provider’s actual efficiency performance. 
 The nature of episodes that make up a provider’s practice experience 
materially affects the volume of episodes necessary to establish a credible 
performance score.   
 The observed coefficient of variance by episode varies significantly, 
contributing to the measured variability by provider specialty type.  The 
required minimum number of episodes needed for a credible efficiency 
performance index, may need to vary by episode and provider specialty 
type. 
 Increasing the minimum episode volume for measuring a provider 
efficiency performance index will result in a lower number of providers 
having sufficient volume of cases for measurement. 
 Most carriers have limitations in data volume required to develop credible 
measures of provider efficiency performance for the majority of providers 
in their networks.  
 Measuring change in provider performance over time may require longer 
experience periods in order to obtain sufficient volumes of new episodes 
for effectively quantifying true changes in practice patterns. 
 Increasing the aggregate claims experience data set size will increase 
episode volumes by provider and correspondingly decrease the experience 
period required to complete measures. 
 Further analysis is warranted to assess volume requirements by specific 
disease or condition being treated, and also to determine if the findings 
change when using different methodologies for measuring provider 
efficiency. 
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 g)  About Hospital Mission Adjustments 
 
Hospitals differ in fundamental ways that affect their cost structures and financial 
status.  For example, it is well established that patient care costs at teaching hospitals are 
higher than costs at non-teaching hospitals, even after adjusting for observed severity of 
illness.  Another example is the disproportionate provision of care by certain hospitals to 
indigent populations who do not have the resources to cover the cost of their care.  These 
hospitals attempt to cover the cost of uncompensated care through higher reimbursements 
from private payers, a phenomenon know as cost shifting. Such examples do not 
necessarily suggest inefficiencies or poor performance on the part of hospitals, but, 
instead, represent the provision of costly services that benefit their communities.   
 
Other examples include: 
 Hospitals with readiness to serve capacity, or special units (burn, trauma, etc.) that 
cater to the needs of the community have higher base costs than hospitals without 
these units. 
 Other facilities have a very high level of uncompensated care and/or 
disproportionate share of Medicaid patients. These facilities have much higher 
variable costs than like facilities without a disfavorable patient mix.  
 
In both cases, these facilities have tended to inflate their prices in order to 
compensate for higher base costs and/or higher variable costs and still accomplish their 
mission.  
 
Third-party payers (TPPs) and administrators (TPAs) are increasingly focused on 
hospital costs, without necessarily recognizing the societal value and associated costs of 
hospital mission-related activities.  In these instances, hospitals’ costs are compared on a 
case-mix adjusted basis only to establish tiered hospital payment models and/or preferred 
hospital networks.  These payment behaviors have the potential to challenge the ability of 
teaching hospitals to pursue their missions of teaching, research, and the provision of 
sophisticated clinical services as well as the potential to impact hospitals that serve the 
uninsured as part of the hospital safety-net system in place in communities.    
 
As reviewed in this White Paper, there are two components of an efficiency index:  
 
Resource-based component  
 Looks at actual resources used such as LOS  
 Neutralizes price  
 Includes appropriate severity adjustment  
 Should reflect efficiency without the need for mission adjustments  
  
Price-sensitive based component   
 Includes costs/case actually paid to hospitals  
 Widely used by plans because it reflects actual cost of care  
 Mission-adjustments in addition to severity adjustments may be warranted 
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Mission adjustments may be important in order to enable more equitable peer-to-peer 
comparisons when using price-sensitive efficiency indices.  
 
The Lewin Group was commissioned by Bridges to Excellence to determine whether 
variations in hospital pricing reflect variations in the following five hospital 
characteristics: 
1. AHC status 
2. Teaching intensity (i.e., intern and residents to bed ratio) 
3. Disproportionate share levels 
4. Specialty facility status (for cardiac surgery) 
5. Payer mix (as an indicator for need to cost shift) 
 
The study conducted by the Lewin Group will determine the relationship of these 
variables to pricing, and will construct potential adjustment factors and then apply them 
to commercial claims databases to test their validity.  If validated, these adjustments will 
be published and incorporated as part of this paper’s recommendations. It is expected that 
the study will be completed by the end of the first quarter in 2005. 
 
We acknowledge that similar research needs to be conducted on physicians.  The decision 
to start with hospitals was based on the existence of prior research in this area and the 
greater ability, at this point, to measure the impact of a mission on a hospital than on a 
physician. 
 
 
